Balance Sheet for Principia Biopharma Inc. (PRNB)

$ 100.05 H   0.00 (0.00%) Volume: 0 4:00 PM EDT 25-Sep-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Cash and Equivalents 39,537 34,489 41,054 5,867
Restrictable Cash - 82 100 100
Marketable Securities 276,043 142,436 - -
Accounts Receivable 1,272 10,000 378 258
Loans Receivable - - - -
Other Receivables 1,272 2,104 378 -
Receivables 1,272 2,104 378 258
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 2,893 1,661 1,400 676
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 319,745 180,772 42,932 6,901
Land and Improvements - - - -
Buildings and Improvement 8,324 420 203 203
Machinery, Furniture and Equipment 3,845 3,400 1,908 1,817
Construction in Progress - - - -
Fixed Assets, Other - - - -
Fixed Assets, Total 12,169 3,820 2,111 2,020
Gross Fixed Assets 12,169 3,820 2,111 2,020
Accumulated Depreciation (2,482) (2,154) (1,902) (1,724)
Net Fixed Assets 9,687 1,666 209 296
Intangibles - - - -
Cost in Excess - - - -
Non-Current Deferred Income Taxes - - - -
Other Non-Current Assets 567 567 82 362
Total Non-Current Assets 62,991 14,749 571 658
Total Assets 382,736 195,521 43,503 7,559
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Accounts Payable 1,850 4,439 3,405 2,126
Short Term Debt - - - 10,364
Notes Payable - - - -
Accrued Expenses 6,393 2,169 1,430 1,091
Accrued Liabilities 6,393 2,169 1,430 1,091
Deferred Revenues - 5,616 44,134 -
Current Deferred Income Taxes - - - -
Other Current Liabilities 7,896 4,656 2,262 4,608
Total Current Liabilities 16,139 16,880 51,231 18,189
Long Term Debt N/A N/A N/A -
Deferred Income Tax 7,619 8,781 5,627 44
Other Non-Current Liabilities 7,619 8,781 7,203 1,094
Minority Interest - - - -
Capital Lease Obligations - - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - - 128,531 104,926
Total Non-Current Liabilities 7,619 8,781 135,734 106,020
Total Liabilities 23,758 25,661 186,965 124,209
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 358,978 169,860 (143,462) (116,650)
Common Par 3 2 1 -
Additional Paid in Capital 544,709 302,393 7,201 5,369
Cumulative Translation Adjustments - - - -
Retained Earnings (185,743) (132,407) (150,574) (121,877)
Treasury Stock - - - -
Other Equity Adjustments 9 (128) (90) (142)
Total Capitalization 358,978 169,860 (143,462) (116,650)
Total Equity 358,978 169,860 (143,462) (116,650)
Total Liabilities & Shareholder's Equity 382,736 195,521 43,503 7,559
Cash Flow (54,061) 18,302 (28,697) (30,638)
Working Capital 303,606 163,892 (8,299) (11,288)
Free Cash Flow (44,717) (22,240) 26,758 (24,856)
Invested Capital 358,978 169,860 (143,462) (116,650)
Shares Outstanding - Common Class Only 32,951 23,865 - -
Preferred Shares Outstanding - - - -
Total Ordinary Shares 32,951 23,865 22,728 22,728
Total Common Shares Outstanding 32,951 23,865 - -
Treasury Shares - - - -
Basic Weighted Shares Outstanding 25,778 7,623 12,942 12,942
Diluted Weighted Shares Outstanding 25,778 8,627 13,794 13,794